Sutro Biopharma (STRO) Other Working Capital Changes (2017 - 2025)

Sutro Biopharma (STRO) has 8 years of Other Working Capital Changes data on file, last reported at -$145000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Working Capital Changes rose 98.24% year-over-year to -$145000.0; the trailing twelve-month figure through Dec 2025 stood at -$69.7 million (down 988.83% YoY), and the FY2025 full-year result was -$69.7 million, down 988.83% from the prior year.
• Other Working Capital Changes climbed to -$145000.0 in Q4 2025, from -$6.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.4 million in Q1 2023 to a low of -$8.0 million in Q3 2025.
• A 5-year average of -$19900.0 and a median of $141000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes jumped 3860.29% in 2022 and plunged 3076.55% in 2023, its largest moves.
• Tracing STRO's Other Working Capital Changes over 5 years: stood at -$2.5 million in 2021, then jumped by 3860.29% to $92.2 million in 2022, then tumbled by 130.46% to -$28.1 million in 2023, then jumped by 70.67% to -$8.2 million in 2024, then soared by 98.24% to -$145000.0 in 2025.
• Business Quant data shows STRO's Other Working Capital Changes at -$145000.0 in Q4 2025, -$6.1 million in Q3 2025, and -$61.7 million in Q2 2025.